Experiences of participation in cardiorespiratory training among people with post-stroke fatigue: a qualitative study.
Maria Svedjebrant, Anna Bråndal, Ylva Nilsagård
PMID 40237418WHAT IT FOUND
People with post-stroke fatigue found home-based, physiotherapist-supervised interval training safe and feasible.
Supervision helped them push past fear of exertion. They reported needing less recovery time and feeling more confident in daily activities, though fatigue persisted.
Key findings
01Supervision by a physiotherapist was crucial for participants to feel safe and reach the intended exercise intensity, which they would not have achieved alone.
02Participants reported that while post-stroke fatigue persisted, they needed less time for recuperation after activity and felt more energetic.
03Training at home reduced stress and dependence on family, and allowed spouses to see the safety of the activity, easing their concerns.
STILL TO COME
How it was doneWhat they foundWhat it means for PTs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The study included only 11 participants who completed the training, so it excludes those who dropped out or could not tolerate the intensity. Participants were selected from an RCT and had mild physical impairments (Modified Rankin Scale 1-2) and no severe cognitive dysfunction, limiting generalizability to more disabled patients. Interviewers were the treating physiotherapists, which may have influenced participants' willingness to report negative experiences. This is a qualitative study of experiences, not a measure of clinical outcomes or efficacy.
The easy way to misread this
Do not interpret these positive experiences as evidence that the training cured fatigue or improved objective fitness measures. The study reports subjective perceptions from a small group of highly selected, motivated patients who completed the program. It does not prove efficacy for the broader post-stroke population.